The complete understanding of the growing catalog of regulatory non-coding RNAs is going to shed light in different aspects of a wide range of pathogenic mechanisms in human diseases. This review was aimed to highlight recent advances in the small noncoding RNA world that could have implications in the development of new strategies in medical sciences. Among the diverse group of small non-coding RNAs, we highlight the group of tRNA-derived fragments as molecules known for a long time which have recently emerged as novel regulators influencing several aspects of cell biology. We describe here recent advances in the field of tRNA-derived fragments playing key roles in the biology of some infectious agents, including E. coli, A. fumigatus, G. lamblia, Ascaris, T. cruzi, Virus, Prions and a brief overview linking them to cancer biology. Additionally, we focus on the potential implications of these molecules in future biotechnological applications in the development of new biomarkers and as new therapeutic targets.
INTRODUCTION
In the last years the comprehension of the small noncoding RNAs (sncRNA) world has been growing thanks to the advance in next-generation sequencing technologies and the discovery of RNA interference (RNAi). Effectors functions of these sncRNAs are achieved through small RNA-associated ribonucleoprotein (RNP) complexes. Based on their origin, the proteins to which they are associated, their biogenesis and the biological process in which they participate, sncRNAs have been grouped into different classes, at present the best known are microRNAs (miRNAs), small-interfering RNAs (siRNAs) and PIWI-related RNAs (piRNAs) [1, 2] . Additionally, novel members of this family of sncRNAs originated from cleavage or processing of already known ncRNAs such as snRNAs, snoRNAs, tRNAs and rRNAs have recently emerged. The tRNA-derived small RNAs, are originated from tRNAs by enzymatic regulated processes [3] [4] [5] [6] [7] [8] . Although tRNA cleavage is not a novelty [9] , it was not until recently that they were defined and classified as new members of the sncRNA family.
Classification and Biogenesis
The classification of each sncRNA molecule inside some family or group is usually established by its biogenesis pathways, structural characteristics and its biological function. In particular, for the small tRNA family, a defined nomenclature for their sub-families or group does not exist yet. This could be due to the fact that they have been recently described and the mechanisms in which they are involved seem to be different from that described for other sncRNAs like miRNAs and siRNAs, making their classification even more difficult.
However, at present it is possible to distinguish two main groups in the small tRNAs family: tRNA halves and tRFs.
tRNA Halves
As depicted in Figure 1 , tRNA halves or tsRNAs are those small tRNAs derived from the cleavage of tRNAs at the anticodon loop, generating both 3' and 5' fragments of 30 -35 nt length [6, 9, 10] . This phenomenon had been described earlier in prokaryotes as consequence of bacteriophage infection [9] , but today it is known to take place in a wide range of eukaryotic cells as consequence of a diverse spectra of stress conditions. For this reason, in some studies these tRNA fragments are also named tiRNAs for tRNA derived stress-induced fragments [5, [7] [8] [11] [12] [13] [14] . This is the case of the first report concerning these small tRNAs found in the ciliate Tetrahymena thermophila as an early adaptive response to starvation caused by essential amino acid deprivation with a possible cell cycle regulation effect [14] . After that, several articles were published describing the cleavage of tRNAs under certain stress conditions, mainly oxidative stress [7, 9, 12, 13, [15] [16] [17] .
The biogenesis of these molecules is still unclear, the position at the anticodon loop in which tRNAs are cleaved differ among organisms and tRNA species, indicating the involvement of some kind of specific endonuclease according to the organism and tRNA structure [14] . It is known that anticodon nucleases are responsible for tRNA cleavage in bacteria [10] , while Angiogenin and Rny1 cause the stress-induced tRNA cleavage in higher eukaryotes cells and fission yeast respectively [16] . Moreover, cleavage seems to occur also on mature tRNAs, since they usually have mature 5' ends, and 3'CCA sequence [16] . Even though certain stress stimuli increase tRNA cleavage, in most cases, the pool of full-length tRNAs levels is not affected and the amount of tRNA halves is lower than that of full-length tRNA, indicating that only a small portion of the mature tRNAs pool is involved in this specific and regulated process [9, 16] .
tRFs
This class of small tRNAs comprises tRNA fragments derived from both the 5' and 3' end of the tRNA, similar to tRNA halves, but in contrast to them, tRFs have a smaller size (~20 nt) as a consequence of different cleavage points in the tRNA molecule. The tRFs originated from 3' end of immature tRNA molecule or pre-tRNA are also included in this class [3, 4, 18, 19] Figure 1 . Even though the three mentioned groups are easily distinguishable, there is no concordance in the literature about tRFs nomenclature. Some authors make reference to the group of tRFs derived of the 5'end through a cleavage in the D loop of mature or immature tRNA as 5'tRFs. Those derived from the cleavage in the T loop of mature tRNA are referred as 3'CCA tRFs (including the 3'end CCA sequence of the mature tRNA), and those derived from the 3' end of immature or pretRNAs that maintain the polyuridines tract, are referred as 3' U tRFs, [19] . Other authors like Lee et al., referred to them as tRF-5, tRF-3 and tRF-1 series, respectively and Haussecker et al., called them Type I and Type II groups in reference to 3' CCA tRFs and 3' U tRFs [3, 4] . As we previously proposed, we will use the terms of 5'tRFs, 3' CCA tRFs and 3'U tRFs for the three reported classes of tRFs [33] .
Ultra-high-throughput sequencing and biological studies made by Lee et al., [4] revealed a precise sequence conservation of the ends of all sequences analyzed, suggesting that a precise cleavage event is necessary to produce each group of small tRFs. For instance, the 3' CCA tRF cleavage site is preferentially located between A/U and U/A and 5'tRF are preferentially cleaved after A [4] . Despite the fact that biogenesis of tRFs has not been fully elucidated and it varies among organisms, it is known that molecules belonging to the tRNA maturation machinery, like the endonuclease RNAse Z, are responsible for the generation of the 3'U tRFs as well as molecules of the miRNA/siRNA pathways, like Dicer, are involved in 5' tRFs and 3'CCA tRFs production [3, 4, 16, 18, 20, 22] . In line with this, some observations were recently made about tRFs biogenesis, on the cleavage of tRNAs and the way in which they are processed in certain kind of cells:  Given the absence of 5' leader sequences in the 5'tRFs as consequence of the RNAse P cleavage in the early process of tRNA maturation, they could be generated at any point of later tRNA processing [3] .  As it was described, their biogenesis could be carried out by Dicer in mammalian cells, and in a Dicerindependent way as was described in Schizosaccharomyces pombe. The differences among 5' tRFs generated in these two organisms, mainly in their size, support the idea that an enzyme other than Dicer is responsible for their production in yeast [19] .  The generation of 3'CAA tRFs also seems to be Dicer-dependent, and it should take place after the
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cleavage by both RNAse P and tRNAse Z, and the addition of CCA; considering that they include the CCA sequence at their 3' ends [3] .  As it was mentioned, 3' U tRFs are formed by the action of tRNAse Z from the pre-tRNA. This process occurs in the nucleus, where tRNA maturation takes place and then tRNA is transported to the cytoplasm. Since 3' U tRFs are found almost exclusively in the cytoplasm it means that after their generation they need to be exported from the nucleus [3, 18] or a cytoplasmic pool of tRNAse Z could be responsible for the generation of 3' U tRFs from tRNAs that exited the nucleus prematurely [23] . Besides these observations, Li et al. have recently described a variety of 5'and 3'tRNA fragments of ~20 nt length Dicer-independent [24] . These results suggest that tRFs are produced by the Angiogenin cleavage (which was mentioned to be involved in the generation of tRNA halves) in human and mouse cells [20] .
Biological Functions
The descriptions mentioned above regarding the regulated biogenesis process of small tRNAs, the stimuli that induce their intracellular increase, and the fact that they are associated with proteins belonging to specific cellular machineries, encouraged authors to suggest that these tRNAs species should have some specific functions in diverse biological process. In this respect, several published works associate small tRNAs with cellular process as translational regulation, cell cycle and cellular proliferation, cell differentiation and virulence [3, 4] . In agreement with the argument made by Pederson about Haussecker's results, the relevance of that work relies on the non canonical miRNA/ siRNA mode of action of these tRFs molecules [8] .
Ivanov et al. [21] have reported that tRNA halves contribute to the dissociation of different forms of the translation initiation factor eIF4G from capped and uncapped mRNA. In addition, they proposed that tRNA halves cooperate with a translational repressor known to displace eIF4G from RNA to negatively regulate translation in stressed cells. The search of alternative sncRNA pathways has been the focus of different works that found the presence of small tRNAs in organisms like Trypanosoma cruzi, for which is well known the lack of canonical RNAi machinery [12, 25] . These findings showed these tRNAs species are interesting players of diverse cellular proesses which involve novel modes of action, independent of their association or not with RNAi mechanisms.
Moreover, if we take into account the list of organisms in which both tRNA-halves and tRFs have been found Table 1 , we can note that they are present throughout the evolutionary scale and more, since they have been associated to exosomes content from prion-infected neuronal cells [26] . In each cell type, they have their specific and novel modes of action, even though they could share 
SMALL TRNAS AND INFECTIOUS DISEASES
Recent advances in sequencing technologies and bioinformatics applied to causative agents of human diseases have stimulated several groups to study the putative role of small tRNAs in a wide range of human pathogens. In a recent review [33] we have highlighted the relevance of these molecules in RNA interference phenomena; here we focus in the description of some examples of pathogens that produce small tRNAs under different conditions ( Table 1) . A deeper knowledge of these novel molecules would give us new tools to manage and to cope with unsolved issues in the pathogenesis of several human infectious diseases.
Escherichia coli
E. coli is a Gram-negative bacterium that is commonly found in the lower intestine of different organisms. Most E. coli strains are harmless, but some strains can cause serious food poisoning in humans, they can cause diarrhea, while others cause urinary tract infections, respiratory illness and pneumonia among other pathological states. E. coli infections are globally increasing in number and severity. It is estimated that this year there will be approximately 76 million illnesses and 5,200 deaths in the United States only attributed to food poisoning outbreaks caused by E. coli O157:H7 and other strains with a mean cost of 50 billion US dollars [27] . In 1990 Levitz and coworkers [11] presented one of the first evidences of specific tRNA cleavage in E. coli by the endoribonuclease Prrc in response to phage T4 infection. In this study the authors adventure the possibility that this tRNA processing pathways could be viewed as a host response to phage division. Later, in 1999, Ogawa et al. [10] found other enzyme, Colicin E5, a special ribonuclease, responsible for the processing of 3' half fragments from tRNA His , tRNA Asn , and tRNA Asp . They demonstrated that the functional role for this RNase is to inhibit protein synthesis of E. coli as a defensive mechanism to cope with phage infection. This bacterial suicide mechanism could be exploited as a tool to eliminate bacterial replication during host infection. A variety of molecules that inhibit protein synthesis have been used longtime to elucidate complicated cell mechanisms and as antibacterial agents. In this respect, it is important to determine whether the activity of Colicin E5 toward the tRNAs reflects the physiological action of this RNase leading to cell death.
Aspargillus fumigatus
A. fumigatus is a filamentous fungi and facultative pathogen for plants and animals with special risk for immunosuppressed patients. The aspergillosis is considered the most common airborne fungal pathogen. The mortality rate of invasive Aspergillosis could reach 90% of cases, depending on the immune status of the host, due to the difficulty of specific diagnostics and therapeutic possibilities [28] . In 2008, Jochl et al. [7] reported the cleavage of tRNA molecules during cell differentiation in A. fumigatus. They didn't find cleavage specificity for certain tRNAs, since all nuclear encoded tRNAs except cytoplasmic tRNA Met , tRNA
Trp and tRNA Asp were identified in the small transcriptome of this fungi. These small tRNA (tRNA halves) were generated by an endonucleolytic cleavage of tRNAs at a position 3' adjacent to the anti-codon loop. The nuclease responsible for this cleavage is unknown but the possible biological function for this process is to downregulate protein synthesis during differentiation [7] . Since conidia represent the resting state of A. fumigatus in the host it is possible that conidial tRNA depletion might be a novel mechanism to down-regulate protein synthesis in this fungus inhibiting the evolution of the disease.
Giardia lamblia
At the same time of the identification of tRNA fragments in A. fumigatus, Li et al. [29] described a particular class of small tRNAs in G. lamblia, named stress-induced tRNA-derived RNA (sitRNAs). The authors revealed a global tRNA cleavage at the anticodon left arm in response to encystations and under different conditions of physicochemical stress. G. lamblia is considered a successful unicellular intestinal parasite due to its ability to reproduce in different and hostile environments by differentiation from a vegetative trophozoite to a cyst form, being a common causative agent of diarrhea and malnutrition [30] . The sitRNAs of G. lamblia are different from those previously described for other organisms since they are a little longer, being about 46 nt in length, and derived from the 3' end of mature tRNAs with a significant fraction having 3' terminal CCA nucleotides. These differences serve as clues for the elucidation of biogenesis pathways for these sitRNAs. Even though the authors didn't find any enzyme responsible for this cleavage in this work, they argue that the main consequence of this phenomenon is down regulation of global gene expression in the parasite [29] . These results may provide new insight into a novel mechanism for G. lamblia to regulate gene expression therefore is a possible new therapeutic target for control of parasite replication in the host.
Trypanosoma cruzi
At present, the families of small no-coding regulatory RNAs (i.e. miRNAs and siRNAs) are recognized as key players in post-transcriptional gene regulation in most eukaryotes. Nonetheless, T. cruzi lacks canonical sRNA pathways [31] . Furthermore, this protozoan has a complex life cycle including diverse cellular forms which alternate between invertebrate and mammalian hosts. To cope with these changes T. cruzi undergoes rapid modifications in gene expression which are achieved essentially at a post-transcriptional level. However the precise mechanisms of this fine tune regulation remain to be elucidated. In a recent effort of our group aimed to identify the presence of alternate sncRNA pathways in T. cruzi clone Dm28c, we reported the presence of a homogeneous population of tRNA halves. In addition we showed that this class of small tRNAs is recruited to particular cytoplasmic organelles in stressed T. cruzi epimastigotes. The main classes of small tRNAs found for T. cruzi were 5' halves of three specific tRNAs [12] . A year later Franzen et al. performed high throughput sequencing of T. cruzi CL Brener epimastigotes in optimal growth conditions and showed that tRNA halves were originated predominantly from the 3' arms and not restricted to particular tRNAs [32] . Despite the wide confirmation for the expression of these small tRNAs in T. cruzi, its biological role remains uncertain. Recent unpublished data from our laboratory showed that small tRNAs are being released as vesicle cargo shed by T. cruzi. Additionally, this cargo is being transferred among parasites and from parasite to host cells, leading to metaciclogenesis transformation and to an increased susceptibility to infection (Submitted manuscript). These results drive us to propose these molecules as possible virulence factors which could be potential drug targets for the control of the disease.
Ascaris
As we have discussed previously [33] it was not until 2010 that the use of deep sequencing techniques allowed researchers to systematically find small tRNAs molecules in eukaryotic pathogens. That is the case of A. suum, a nematode parasite closely directed to A. lumbricoides. A. lumbricoides affects 1 billion people worldwide and is considered an important neglected disease [34] . Wang et al. in 2011 performed deep small RNA transcriptome sequencing of this parasite and identified a diversity of sRNA classes including RNAs of 32 nt with a 5' monophosphate. Many of these sRNAs were derived from snoRNAs and tRNAs, among others. They verified the presence of small tRNAs in the small transcriptome of Ascaris but these molecules were not the focus of this study. The work of these authors sheds a vast amount of data that needs to be analyzed deeper in respect to small tRNAs, for example to systematically catalog the expression of small tRNAs through male and female reproducetive systems, during zygote maturation, and all stages of development [8] . Although there is no direct evidence relating these molecules to Ascaris pathogenesis, they should not be dismissed considering their potential relevance in related infectious agents.
Virus: HIV, Respiratory Syncytial Virus and Herpes Simplex Virus
The etiology and worldwide pandemic significance of viral diseases such as AIDS and human respiratory Syncytial virus (RSV) (the most common cause of bronchiolitis and pneumonia in babies) go beyond the scope of this review. We intended simply to highlight the most relevant knowledge on small tRNAs that would allow future biomedical applications. It is known today that viral reverse transcriptases use tRNAs (commonly tRNA Lys , tRNA Pro , or tRNA Trp ) as primers for the initiation of reverse transcription and DNA viral synthesis [36] . Yeung et al. [37] have previously reported the identification of a 18 nt small RNA, originated from the double-stranded RNA hybrid formed by the HIV RNA and the 3' end of the human cellular tRNA Lys . The authors used luciferase reporter assays to show silencing activity produced by the union of this tRNA Lys , considered as a 3'tRF, with Dicer and AGO2. These results allowed the authors to propose a function for tRFs in RNAi machinery, targeting HIV and viral defense. We would like to point here a finding by Reese et al. [38] in 2010, not specific for tRFs but for tRNA molecules of interest for this review. In this study the authors reported that mammalian herpes viruses could exploit tRNA biogenesis pathways to produce fully functional viral miRNAs. In this system, molecules of 50 nts derived from tRNAs produced by RNA Pol III are aligned with a pre-miRNA hairpin of 30 nts and cleaved by RNase Z to liberate the pre-miRNA hairpins. These pre-miRNAs are further processed to mature viral miRNAs by Dicer [38] . This is an original report in which tRNA molecules different of tRFs could act as gene control factors. Recently Wang et al. [39] have used high throughput sequencing to identify sncRNAs in cells infected with RSV. They found that RSV infection generates a large production of 5'-derived tRFs of about 30 nts long and the processing of this tRFs appeared to be specific of the endonuclease Angiogenin. Moreover at least for tRFs from tRNA-Glu-CTC they showed a possible role suppressing target mRNA and supporting RSV replication. We could conclude that this work provides original information on the possibility of future uses for tRFs as inhibitors of viral infections.
Prions
In the last few years, numerous reports have highlighted the role of exosomes in diverse biological processes such as antigen presentation, immune response, cell to cell communication and burden of infectious pathogens [40] .
In addition, exosomes carry as cargo mRNA and miRNAs that could be delivered to other cells and be totally functional in receptor cells [41] . Prion diseases constitute a group of transmissible neurodegenerative disorders, invariably fatal, that include bovine spongiform encephalopathy among others, where the main symptoms are dementia, neuronal loss, spongiform change and death. One model of prion propagation proposes that these diseases are associated with the conformational conversion of the host cellular prion protein into an abnormal pathogenic isoform by a protein guide directed mechanism. Diagnosis and treatment of prion disease is almost impracticable by the absence of effecttive pre-mortem diagnostic methods. The identification of non-invasive, sensitive and specific diagnostic markers during the pre-clinical phase is of major importance [42] . Recently, Bellingham et al. [26] analyzed the small RNA cargo of uninfected and prion-infected exosomes by deep sequencing. Surprisingly, these authors demonstrated that exosomes released from prion-infected neuronal cells contain a variety of small RNA where 90 % corresponded to small tRNAs. Additionally, they reported a specific miRNA signature in exosomes released from prion-infected neuronal cells. They discuss the possible role of exosomes in miRNAs delivery during prion infection disease that could be of interest for diagnostics [26] .
Cancer
We are not going to dwell here since it is out of the scope of this review, but a description of small tRNAs implications in human pathogenesis would be incomplete without pointing out the advances in the field of cancer biology. The relation of small tRNAs and cancer are described deeper in a recent review by Martens-Uzunova et al. [43] . The authors compile evidence since the first isolation of a small tRNA molecule almost 30 years ago from human urinary bladder carcinoma to nowadays with data provided by next generation sequencing. These data led to the identification of small tRNAs of different size, class and origin on a genome wide scale. Studies of Cole et al. [6] and Kawaji et al. [44] , revealed that small tRNAs are one of the main populations of sRNAs found in cancer cell lines. These authors provided experimental evidences showing different expression patterns of these molecules between normal and cancer cells. These findings are closing to complete the molecular overview of this disease.
BIOTECHNOLOGICAL ASPECTS OF SMALL TRNAS
Similarly to miRNAs and siRNAs, small tRNAs are becoming as valuable research and biotechnological tools in cell biology and medicine.
Microarrays
Saikia and co-workers [45] have made use of microarray technology to evaluate patterns of tRNA cleavage in response to different stress sources in murine cells. They designed customized microarray chips containing sequences of mouse nuclear-encoded tRNAs, as well as other yeast and Escherichia coli tRNA probes for hybridization and normalization controls. To ensure that only tRNA fragments were detected and to avoid interference from mature tRNAs, total RNA from treated cells was size-fractioned (retaining only RNAs 30 -40 nt in length) and stringent hybridization conditions were applied. This approach allowed them to identify cleavage patterns characteristic of certain types of stress and to further understand the processes underlying tRNA fragments generation. Such genome-wide strategies could provide insights into the role of tRNA fragments in pathways involved in numerous disorders and conditions if applied adequately.
Gene Silencing
A remarkable example of the biotechnological application of tRFs is that of the TRUE gene silencing technology, developed by Nashimoto and collaborators. TRUE gene silencing stands for tRNase Z L -utilizing efficacious gene silencing [23, [46] [47] . tRNaseZ L is the long form of tRNaseZ, the enzyme responsible for removing the 3' trailer from precursor tRNA (pre-tRNA), a key step in tRNAs maturation. tRNaseZ has also been implied in the generation of certain classes of tRFs [19] . In a series of studies, Nashimoto's group demonstrated the ability of tRNaseZ L to cleave any target RNA at any desired site by recognizing a pre-tRNA-like or micropre-tRNA-like complex formed between the target RNA and an artificially-designed small guide RNA (sgRNA). They describe several classes of sgRNA, including 5'-tRNA-halves.
In their initial work, they report that 5'-tRNA-halves were able to act as sgRNAs to cleave at specific sites two HIV mRNAs (ENV and GAG) [48] . Ten years later, they were able to downregulate the expression of two endogenous human genes (Bcl-2 and GSK-3β), using tRNaseZ L and sgRNAs, and propose the term TRUE gene silencing for this technology [47] . Later on, they were successful at inhibiting the endogenous human vascular endothelial growth factor (VEGF) gene expression using this methodology, with tRNA halves (and others) as sgRNAs [23] . Finally, they showed that miRNAs can also act as sgRNAs, directing the cleavage of target mRNAs by tRNaseZ L in human cells [23] . In the last years they expanded the possibilities of TRUE gene si-lencing by demonstrating that a certain kind of sgRNAs can readily be incorporated in human cells and efficiently eliminate target miRNAs [49] .
Interestingly, the silencing effect using sgRNAs greatly surpassed that of siRNAs in some cases, both for endogenous genes and in luciferase assays. The authors also suggested that this technology should be safer than siRNAs, since potential off-target effects of sgRNAs are expected to be less serious than those induced by siRNAs because sgRNAs target a smaller region in the mRNA than siRNAs. These are two desirable characteristics of potential therapeutic agents for several diseases.
In line with these findings, Scherer et al., in search for more efficient and controlled short hairpin RNA (shRNA) expression systems, designed a tRNA-shRNA chimera expression construct under the control of tRNA promoters. Their results indicate that tRNaseZ L cleaves the tRNA-shRNA chimera, since these chimeras resemble the normal substrate of the enzyme, therefore releasing the hairpin which is then incorporated in the RNA interference machinery, regulating the expression of the targeted genes [50] .
Biomarker Potential
Much remains to be understood regarding tRNA fragments' role in diseases. However, growing evidence indicates that they are implicated in a range of disorders, including cancer [51] , inflammatory diseases [52] and viral infection [39] . As was the case of miRNAs, research in the field of tRNA fragments is likely to increase rapidly, and information about their involvement in certain diseases will soon become available. Interestingly, small tRNAs patterns in cancer cell lines were reported profoundly altered when compared to normal counterparts [6, 44] . Additionally, a line of active current research is the study of circulating small RNAs in serum, plasma, and other body fluids, contained in extracellular vesicles, which may represent an interesting niche for the search of noninvasive biomarkers in cancer and other complex diseases [53, 54] . Certain tRNA fragments have been identified in \microvesicles from immune cells [55] and prion-infected neuronal cells [26] , and further research in this direction should provide useful tools for diagnosis.
CONCLUDING REMARKS
The complete understanding of a sncRNA scenario in cell biology will provide valuable information for their future applications in biomedicine especially in the field of biomarker development and new therapeutic approaches. One of these promising molecules are small tRNAs which were intensively studied in the last decade as specific products of regulated pathways and not merely results of nonspecific degradative processes. This review was aimed to point out the relevance of these findings for some pathogens and diseases that have been done in this area.
We presented as examples the findings achieved in tRFs field for: Bacteria as E. coli [10, 11, 15] , Fungus as A. fumigatus [7] , Protozoas as G. lamblia [29] and parasites as T. cruzi and Ascaris [35] ; Viruses as HIV [37, 46, 48, 56] , Herpes [38] and RSV [39] ; and neurodegenerative agents as Prions [26] ; last we wanted to briefly note, not in depth, the case for cancer [6, 44] . Briefly all the authors observe the production of these small tRNAs under different stimuli that could be stress, cell cycle progression and/or infection by a pathogen agent. The consequences or biological roles of the expression of these molecules is not completely defined but could lead cells to down-regulate protein synthesis and mRNA silencing, as the cases for small tRNAs of G. lamblia [29] , A. fumigatus [7] and virus [39] .
Efforts should be focused on the complete description of small tRNAs and its role as virulence factors, drug targets, biomarkers or as relevant molecules for infection.
With further research effort it is likely that technologies based on small tRNAs will develop and more applications will arise. It is of particular interest their use as non-invasive biomarkers for the diagnosis of certain diseases and as sgRNAs in gene therapeutic approaches.
